» Authors » Patrizia Gazzerro

Patrizia Gazzerro

Explore the profile of Patrizia Gazzerro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 91
Citations 1568
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Grisi F, Troiano R, Fiore D, Gazzerro P, Lettieri M, Venditto V, et al.
Molecules . 2025 Jan; 29(24. PMID: 39770029
Plastic pollution is a global problem affecting the environment and, consequently, people's well-being. Careful and timely end-of-life plastic recycling is certainly a way, albeit a partial one, to remedy the...
2.
Di Zazzo E, Rienzo M, Casamassimi A, Gazzerro P, Abbondanza C
Front Biosci (Landmark Ed) . 2024 Sep; 29(9):316. PMID: 39344327
No abstract available.
3.
Sardo C, Auriemma G, Mazzacano C, Conte C, Piccolo V, Ciaglia T, et al.
Pharmaceutics . 2024 Aug; 16(8). PMID: 39204316
In this study, the structural attributes of nanoparticles obtained by a renewable and non-immunogenic "inulinated" analog of the "pegylated" PLA (PEG-PLA) were examined, together with the potential of these novel...
4.
Di Donato M, Di Zazzo E, Salvati A, Sorrentino C, Giurato G, Fiore D, et al.
J Transl Med . 2023 Oct; 21(1):736. PMID: 37853459
Background: Colorectal cancer (CRC) is the third most deadly and fourth most diagnosed cancer worldwide. Despite the progress in early diagnosis and advanced therapeutic options, CRC shows a poor prognosis...
5.
Proto M, Fiore D, Bifulco M, Gazzerro P
Int J Mol Sci . 2023 Sep; 24(17). PMID: 37686233
The spread of breast cancer to distant sites is the major cause of death in breast cancer patients. Increasing evidence supports the role of the tumor microenvironment (TME) in breast...
6.
Di Zazzo E, Rienzo M, Casamassimi A, De Rosa C, Medici N, Gazzerro P, et al.
J Transl Med . 2023 Mar; 21(1):217. PMID: 36964555
Background: T cell activation and programming from their naïve/resting state, characterized by widespread modifications in chromatin accessibility triggering extensive changes in transcriptional programs, is orchestrated by several cytokines and transcription...
7.
Pagano C, Di Zazzo E, Avilia G, Savarese B, Navarra G, Proto M, et al.
Int J Cancer . 2022 Nov; 152(12):2464-2473. PMID: 36366852
The epidemic spread of obesity is nowadays recognized as a global health and economic burden, arising great interest in the scientific community. The rate of adult obesity steadily increases concomitantly...
8.
Fiore D, Proto M, Franceschelli S, Pascale M, Bifulco M, Gazzerro P
Biomedicines . 2022 Sep; 10(9). PMID: 36140223
Despite the progressions in COVID-19 understanding, the optimization of patient-specific therapies remains a challenge. Statins, the most widely prescribed lipid-lowering drugs, received considerable attention due to their pleiotropic effects, encompassing...
9.
Proto M, Fiore D, Piscopo C, Laezza C, Bifulco M, Gazzerro P
Front Pharmacol . 2022 May; 13:815646. PMID: 35559231
Glioblastoma (GBM) is the most common and lethal primary malignant brain tumor, and due to its unique features, its management is certainly one of the most challenging ones among all...
10.
Covelli V, Grimaldi M, Randino R, Firoznezhad M, Proto M, De Simone V, et al.
Molecules . 2021 Dec; 26(23). PMID: 34885721
N6-Isopentenyladenosine () is a naturally occurring modified nucleoside displaying in vitro and in vivo antiproliferative and pro-apoptotic properties. In our previous studies, including an in silico inverse virtual screening, NMR...